acute toxicity study - virgo uap · acute oral toxicity study of test drug “m.vita capsule” on...
TRANSCRIPT
Acute Oral Toxicity Study on
M.VITA CAPSULE
OF
Sponsor Study Centre:
VIRGO UAP PHARMA PVT.LTD. PHARMACOLOGY LABORATORY MAHAGUJARAT IND.ESTATE , SDM CENRE FOR RESEARCH IN PLOT NO. 423/98-B. AYURVEDA AND ALLIED SCIENCES SARKHEJ – BAVLA HIGHWAY LAXMI NARAYANA NAGAR, KUTHPADY, VILL – MORAIYA, TA – SANAND UDUPI - 574118 DIST – AHMEDABAD - 382213 Email: [email protected] Web: www.virgouap.com
2
STUDY REPORT
Evaluation of “M.VITA CAPSULE” for safety
profile
Acute Oral Toxicity Study (OECD 425)
Project Director
Dr. B. Ravishankar
Chief Investigator
Mr. Ravi M
Pharmacology Laboratory
SDM Centre for Research in Ayurveda and Allied Sciences,
Kuthpady, Udupi-
3
SINDEX
Title
Page No.
Index
3
Investigators conclusion
4
Details of experiments
5
Materials and methods
6-9
Observation
9
Result
10
Conclusion
11
Data sheet 12-21
4
Acute toxicity study:
This study determines acute toxicity of “M.Vita Capsule” an oral formulation prepared with
suspension of test drug using gum acacia, in rats was assessed for single dose acute toxicity by
employing OECD guidelines 425 using AOT software. The dosed (up down as per requirement)
rats were observed for 14 days, for general appearance, cage side behaviour including increased
or decreasing motor activity, convulsions, straub’s reaction, catatonia, muscle spasm, spasticity,
ophisthotonus, hyperesthesia, muscle relaxation, anaesthesia, arching and rolling, lacrimation,
salivation, diarrheal, writhing movement, mode of respiration and changes in skin colour etc.,
with mortality and autopsy finding in case of dead animal.
Conclusion:
The test drug did not produce any mortality up to the dose of 2000mg/kg per oral which is
equivalent to 22.4g total dose for a human being weighing 70 kg man. At the dose level studied
the drug also did not produce any observable toxic effect except for mild irritation in animal in
the dose550mg/kg and 2000mg/kg. Based on the observation made and recorded it can be
concluded that the test drug is without any toxic potential even at the dose of 2000mg/kg in
animals equivalent to 22.4g for human being. This dose in human being is 14 fold in
comparison to normal human dose 1.6g per day.
Mr. Ravi M Dr .B. Ravishankar
M.Sc (Medical Pharmacology) M.Sc (Med Pharmacology)., Ph.D
Research Officer Director and Professor or Exptl Medicine
Pharmacology and Toxicology Lab
SDM Centre for Research in Ayurveda and Allied Sciences
Udupi- 574 118
Karnataka State
5
Acute oral toxicity study of test drug “M.Vita Capsule” on rats
Date of experiment : 06-01-12
Acclimatization of animals : 7 days
Date of treatment : 13-01-12
End of experiment : 05-02-12
Observation period : 14 days
Regulatory guidelines followed : OECD test guideline No. 425
IAEC approved number : IAEC-12/11-SDMCRA SP/02
6
2. Materials methods:
2.1 Details of test formulation:
1. Name of the test formulation : M.Vita Capsule
M.Vita Capsule- Information about name and quantity of the ingredients Ingredients name
Botanical name Part or form used
Book Ref Quantity
1.Makardhvaj Rasa ---- Powder B.B.R.1908 10 mg
2-Suddha Shilajit Aspholtum Punjabinum Exudate A.B. 40 mg
3- Abhrak Bhasma ---- Powder R.T.S. -1 10 mg
4- Loha Bhasma ---- Powder R.T.S. -1 30 mg
5- Yashad Bhasma --- Powder R.T.S. -1 10 mg
6- Suvarna Makshik Bhasma
---- Powder R.T.S. -1 10 mg
7- Praval Pishti --- Powder R.T.S. -1 10 mg
8- Ashwagandha Withania somnifera Root A.P.I. 40 mg
9- Shatavari Asparagus racemosus Root A.P.I. 40 mg
10- Moosali Asparagus adscendens Root A.B. 20 mg
11- Gokshur Tribulus terrestris Fruit A.P.I. 30 mg
12- Javantri Myristica fragrans Aerial Part A.B. 10 mg
13- Pipali Piper longum Fruit A.P.I. 10 mg
14- Dalchini Cinnamomum zeylanicum Stem Bark A.P.I. 20 mg
15- Suddha Kauch Beej Mucuna puriens Seed A.B. 30 mg
16- Suddha Kuchala Beej Strychnos nuxvomica Seed A.P.I. 30 mg
17- Bidhara Rourea santaloides Stem A.B. 30 mg
18- Lavang Syzygium aromaticum Flower Bud A.P.I. 10 mg
19- Balabeej Sida cordifolia Seed A.B. 10 mg
20- Yastimadhu Glycyrrhiza glabra Root A.P.I. 20 mg
21- Ext. Haridra Curcuma longa Rhizome A.P.I. 10 mg
22- Excipients Q.S.
2. Batch number : MCA01 (Trial batch for product permission and mfg. Licence)
3. Manufacturing date : December 2011
4. Expiry date : November 2016
5. Storage condition : Cool and dry place
6. General use : Energy Capsule for Vigour & Vitality.
7. CAS number : APPLIED
9. Country of origin : India
7
10. Manufacturer’s name : VIRGO UAP Pharma Pvt.Ltd.
Mahagujarat Ind.Estate Plot no. 423/ 98-B, Sarkhej - Bavala
highway, Vill - MORAIYA, Ta - Sanand Dist - AHMEDABAD -
382213(GUJARAT)
2.2- TEST CONDITIONS
1. Animal species : Rats
2. Strain : Wistar albino
3. Source : Animal house attached to SDM Research centre, SDM
Ayurveda College Udyavara
4. Selection : A total of 5 healthy either sex of body weight 150-200g
Rats were selected according to AOT software .
5. Acclimatization period : All the selected animals were kept under
acclimatization For 7 days before dosing.
6. Numbering and identification : The animal were marked with saturated
Picric acid solution in water for proper
identification. The marking within the
cages is as follows.
Animal number
Marking
1 Head
2 Neck
3 Middle of the back
4 Base of the tail
5 No mark
8
The group number, animal number and sex of the animal were identified with the help of cage cards,
as presented in following table.
Sl. no
Identification of animals
Desired dose (according to AOT)
Body weight (grams )
Calculated dose (ml)
1 Head 175mg/kg 125 0.5ml
2 Neck 550mg/kg 155 1.03 ml
3 Back 2000mg/kg 130 3.2ml
4 Base of the tail 2000mg/kg 160 3.25ml
5 No mark 2000mg/kg 225 5.6ml
Husbandry condition:
1. Housing : Rats were housed in each cage of poly propylene with stainless steel top
grill. The dry husk was used as bedding material and was changed every
morning.
2. Environment : The animal were exposed to 12 hours light and 12 hours dark cycle with
The relative humidity 50 to 70 % and the ambient temperature was
22 ± 03®c.
3. Diet : Amruth brand rat pellete feed supplied by Pranav Agro Ltd, was provided
throughout the study period except on previous night of dosing i.e
(overnight) fasting before dosing. The drinking water was given ad
libitum Propylene bottles with stainless steel sipper tube.
9
.
2.4 Preparation of Test formulation for administration:
1. Test drug : M-VITA CAPSULE
2. Vehicle : Gum acacia 3. Dose preparation : The test formulation supplied by the sponsor was made in to Fine suspension in vehicle with suitable concentration All the animal were dosed constant dose volume (1 ml/ 100g body weight) 175mg/kg , 550mg/kg, 2000mg/kg 4. Schedule : Single dose per animal a) Administration : The test formulation was administered through oral route at different dose levels to respective animal through oral feeding needle on to disposable syringe b) Dose fixation : According to the AOT Software. C) Route : Oral d) Dose : 175mg/kg, 550mg/kg, 2000mg/kg test substance
e) Dose volume : 1ml/100g animal
3. Observation:
3.1 Examination of Physical and Behavioural changes :
The animal was observed continuously for 4 hours after the dosing. The careful cage side
observation was done without disturbing the animal attention and at the end of the every hour
the animal were individually exposed to open arena for recording the behavioural changes like
increased or decreased motor activity , convulsions, straub’s reaction, muscle spasm, catatonia,
spasticity, ophisthotonus , hyperesthesia , muscle relaxation, anaesthesia, arching and rolling,
lacrimation, salivation , diarrhoea, writhing , mode of respiration, changes in skin colour etc.
exitus, CNS depression – hypo activity, passivity, relaxation, ataxia, narcosis, etc.
3.2 Mortality:
All the animals were observed at ½, 1, 2, 3, 4, 24 h, 48 h after dosing and there after daily
once for mortality during the entire period of the study (i.e.14 days).
10
4. RESULT:
4.1 Physical and behavioural examination:
There were no physical and behavioural changes-(except mild increase in motor activity and
irritability seen in animal group 550mg/kg and 2000mg/kg) in all the treated animals on day one
at ½, 1,2,3,4 hours intervals after dosing and there after once daily for 14 consecutive days. Thus
the data obtained from the study on single dose administration of M.Vita Capsule oral
administration up to 14 days of observation period does not result in any physical and
behavioural changes.
4.2 Mortality:
All the animals belonging to the treated group survived throughout the 14 days observation
period after dosing.
11
Conclusion:
The test drug did not produce any mortality up to the dose of 2000mg/kg per oral
which is equivalent to 22.4g total dose for a human being weighing 70 kg man. At
the dose level studied the drug also did not produce any observable toxic effect
except for mild irritation in animal in dose550mg/kg and 2000mg/kg and thus it
could be concluded that the test drug is without any toxic potential even at the
dose of 2000mg/kg in animals equivalent to 22.4g for human being.
Dr. B. Ravishankar
12
Pharmacology Laboratory
SDM Centre for Research in Ayurveda & Allied Sciences, Udupi PRO FORMA FOR RECORDING SIGNS AND SYMPTOMS DURING ACUTE TOXICITY STUDIES
Group: 175mg /kg Date: 13/01/12 Dose: 0.5ml
Animal: Rat 1(125g) Route: Oral Drug: M.Vita Capsule
Experiment conducted by: Head of the lab (Director):
N: Normal
SIGNS & SYMPTOMS Basal 30min 1hrs 2hrs 3hrs 4hrs 24hrs 48hrs
General impression N N ACTIVE N N N N N Increased motor activity - - + + + - - - Convulsion: Tonic - - - - - - - -
Clonic - - - - - - - - Straubs reaction - - - - - - - - Muscle spasm - - - - - - - - Catatonia - - - - - - - - Opisthotonus - - - - - - - - Hyperaesthesia - - - - - - - - Decreased motor activity - - - - - - - - Muscle relaxation - - - - - - - - Anaesthesia - - - - - - - - Arching and rolling - - - - - - - - Lacrimation - - - - - - - - Diarrhoea - - - - - - - - Writhing - - - - - - - Salivation Viscid - - - - - - - -
Watery - - - - - - - - Respiration Stimulation - - - - - - - -
Depression - - - - - - - - Failure - - - - - - - -
Skin colour Blanching - - - - - - - - Cyanosis - - - - - - - -
Vasodilatation - - - - - - - - Grip strength(kg)-mean N N N N N N N N Visual placing response N N N N N N N N Tail pinch response N N N N N N N N Auditory response N N N N N N N N mucus membrane N N N N N N N N
Piloerection - - - - - - - -
13
Pharmacology Laboratory
SDM Centre for Research in Ayurveda & Allied Sciences, Udupi PRO FORMA FOR RECORDING SIGNS AND SYMPTOMS DURING ACUTE TOXICITY STUDIES
Group: 550mg/kg Date: 16/01/12 Dose: 1.03ml
Animal: Rat-2(155g) Route: Oral Drug: M.Vita Capsule
Experiment conducted by: Head of the lab (Director):
SIGNS & SYMPTOMS Basal 1/2 1h 2h 3h 4h 24h 48h
General impression N N Active Active Active Active N N Increased motor activity - - - + - - - - Convulsion: Tonic - - - - - - - -
Clonic - - - - - - - - Straubs reaction - - - - - - - - Muscle spasm - - - - - - - - Catatonia - - - - - - - - Opisthotonus - - - - - - - - Hyperaesthesia - - - - - - - - Decreased motor activity - - - - - - - - Muscle relaxation - - - - - - - - Anaesthesia - - - - - - - - Arching and rolling - - - - - - - - Lacrimation - - - - - - - - Diarrhoea - - - - - - - - Writhing - - - - - - - Salivation Viscid - - - - - - - -
Watery - - - - - - - - Respiration Stimulation - - - - - - - -
Depression - - - - - - - - Failure - - - - - - - -
Skin colour Blanching - - - - - - - - Cyanosis - - - - - - - -
Vasodilatation - - - - - - - - Grip strength(kg)-mean N N N N N N N N Visual placing response N N N N N N N N Tail pinch response N N N N N N N N Auditory response N N N N N N N N mucus membrane N N N N N N N N
Piloerection - - - - - - - -
14
Pharmacology Laboratory
SDM Centre for Research in Ayurveda & Allied Sciences, Udupi PRO FORMA FOR RECORDING SIGNS AND SYMPTOMS DURING ACUTE TOXICITY STUDIES
Group: 2000mg/kg Date: 19/01/12 Dose: 3.25ml
Animal: Rat-3(130g) Route: Oral Drug: M.Vita Capsule
Experiment conducted by: Head of the lab (Director):
N: Normal
SIGNS & SYMPTOMS Basal 1/2 1h 2h 3h 4h 24h 48h
General impression N N ACTIVE Active active N N N Increased motor activity - - + + + - - - Convulsion: Tonic - - - - - - - -
Clonic - - - - - - - - Straubs reaction - - - - - - - - Muscle spasm - - - - - - - - Catatonia - - - - - - - - Opisthotonus - - - - - - - - Hyperaesthesia - - - - - - - - Decreased motor activity - - - - - - - - Muscle relaxation - - - - - - - - Anaesthesia - - - - - - - - Arching and rolling - - - - - - - - Lacrimation - - - - - - - - Diarrhoea - - - - - - - - Writhing - - - - - - - Salivation Viscid - - - - - - - -
Watery - - - - - - - - Respiration Stimulation - - - - - - - -
Depression - - - - - - - - Failure - - - - - - - -
Skin colour Blanching - - - - - - - - Cyanosis - - - - - - - -
Vasodilatation - - - - - - - - Grip strength(kg)-mean N N N N N N N N Visual placing response N N N N N N N N Tail pinch response N N N N N N N N Auditory response N N N N N N N N mucus membrane N N N N N N N N
Piloerection - - - - - - - -
15
Pharmacology Laboratory
SDM Centre for Research in Ayurveda & Allied Sciences, Udupi PRO FORMA FOR RECORDING SIGNS AND SYMPTOMS DURING ACUTE TOXICITY STUDIES
Group: 2000mg/kg Date: 21/01/12 Dose: 3.125ml Animal: Rat-4(160g) Route: Oral Drug: M.Vita Capsule
Experiment conducted by: Head of the lab (Director):
N: Normal
SIGNS & SYMPTOMS Basal 1/2 1h 2h 3h 4h 24h 48h
General impression N N N Active Active N N N Increased motor activity - - - - - - - - Convulsion: Tonic - - - - - - - -
Clonic - - - - - - - - Straubs reaction - - - - - - - - Muscle spasm - - - - - - - - Catatonia - - - - - - - - Opisthotonus - - - - - - - - Hyperaesthesia - - - - - - - - Decreased motor activity - - - - - - - - Muscle relaxation - - - - - - - - Anaesthesia - - - - - - - - Arching and rolling - - - - - - - - Lacrimation - - - - - - - - Diarrhoea - - - - - - - - Writhing - - - - - - - Salivation Viscid - - - - - - - -
Watery - - - - - - - - Respiration Stimulation - - - - - - - -
Depression - - - - - - - - Failure - - - - - - - -
Skin colour Blanching - - - - - - - - Cyanosis - - - - - - - -
Vasodilatation - - - - - - - - Grip strength(kg)-mean N N N N N N N N Visual placing response N N N N N N N N Tail pinch response N N N N N N N N Auditory response N N N N N N N N mucus membrane N N N N N N N N
Piloerection - - - - - - - -
16
Pharmacology Laboratory
SDM Centre for Research in Ayurveda & Allied Sciences, Udupi PRO FORMA FOR RECORDING SIGNS AND SYMPTOMS DURING ACUTE TOXICITY STUDIES
Group: 2000mg/kg Date: 23/01/12 Dose: 5.6ml
Animal: Rat-5(225g) Route: Oral Drug: M.Vita Capsule
Experiment conducted by: Head of the lab (Director):
N: Normal
SIGNS & SYMPTOMS Basal 30 min 1h 2h 3h 4h 24h 48h
General impression N N active N N N N N Increased motor activity - - - - - - - - Convulsion: Tonic - - - - - - - -
Clonic - - - - - - - - Straubs reaction - - - - - - - - Muscle spasm - - - - - - - - Catatonia - - - - - - - - Opisthotonus - - - - - - - - Hyperaesthesia - - - - - - - - Decreased motor activity - - - - - - - - Muscle relaxation - - - - - - - - Anaesthesia - - - - - - - - Arching and rolling - - - - - - - - Lacrimation - - - - - - - - Diarrhoea - - - - - - - - Writhing - - - - - - - Salivation Viscid - - - - - - - -
Watery - - - - - - - - Respiration Stimulation - - - - - - - -
Depression - - - - - - - - Failure - - - - - - - -
Skin colour Blanching - - - - - - - - Cyanosis - - - - - - - -
Vasodilatation - - - - - - - - Grip strength(kg)-mean N N N N N N N N Visual placing response N N N N N N N N Tail pinch response N N N N N N N N Auditory response N N N N N N N N mucus membrane N N N N N N N N
Piloerection - - - - - - - -
17
Pharmacology Laboratory
SDM Centre for Research in Ayurveda & Allied Sciences, Udupi Proforma for recording effect on gross behaviour
Drug : M. Vita Capsule Date : 13/01/12
Group: 175mg/kg Route: Oral
Animal: Rat1 (125) Study: acute oral toxicity
Experiment conducted by: Head of the lab (Director):
Rat
No
.1
Tim
e o
f d
rug
ad
min
istr
ati
on
Tim
e i
nte
rval
(min
)
Exit
us
CNS Depression
ANS
CNS Stimulation
An
alg
esi
a
Oth
ers
Hyp
o a
ctiv
ity
Pass
ivit
y
Rel
ax
ati
on
Ata
xia
Narc
osi
s
Pto
sis
Exop
hth
alm
os
es
Hyp
era
ctiv
ity
Irri
tab
ilit
y
Ste
reo
typ
y
Tre
mors
Con
vu
lsio
n
Str
au
b t
ail
Basal - - - - -- - - - - - - - - - -
11.00
30 - - - - - - - - + + - - - - -
60 - - - - - - - - + + - - - - -
120 - - - - - - - - - - - -- - - -
180 - - - -- - - - - - - - -- -- - -
240 - - - - - - - - - - - - - --
24
h
- - - - - - - - - - - - - - -
48
h
- - - - - - - - - - - - - - -
18
Pharmacology Laboratory
SDM Centre for Research in Ayurveda and Allied sciences, Kuthpady, Udupi-
574118.
Pro forma for assessing Gross behaviour
Drug : M. Vita Capsule Date : 16/01/12
Group : 550mg/kg Route: Oral
Animal: Rat -2 155g Study: Acute oral toxicity
Experiment conducted by: Head of the lab (Director):
Rat
No.2
Tim
e of
dru
g
ad
min
istr
ati
on
Tim
e i
nte
rval
(min
)
Exit
us
CNS Depression
ANS
CNS Stimulation
An
alg
esi
a
Oth
ers
Hyp
o a
ctiv
ity
Pass
ivit
y
Rel
axati
on
Ata
xia
Narc
osi
s
Pto
sis
Exop
hth
alm
os
es
Hyp
eract
ivit
y
Irri
tab
ilit
y
Ste
reoty
py
Tre
mors
Con
vu
lsio
n
Str
au
b t
ail
Basal - - - - -- - - - - - - - - - -
11.00
30 - - - - - - - - + + - - - - -
60 - - - - - - - - + + - - - - -
120 - - - - - - - - + + - -- - - -
180 - - - -- - - - - - - - -- -- - -
240 - - - - - - - - - - - - - --
24
h
- - - - - - - - - - - - - - -
48
h
- - - - - - - - - - - - - - -
19
Pharmacology Laboratory
SDM Centre for Research in Ayurveda and Allied sciences, Kuthpady, Udupi-
574118.
Pro forma for assessing Gross behaviour
Drug : M.Vita Capsule Date : 19/01/12
Group : 2000mg/kg Route: Oral
Animal: Rat -3(130g) Study: Acute oral toxicity
Experiment conducted by: Head of the lab (Director):
Rat
No.3
Tim
e of
dru
g
ad
min
istr
ati
on
Tim
e i
nte
rval
(min
)
Exit
us
CNS Depression
ANS
CNS Stimulation
An
alg
esi
a
Oth
ers
Hyp
o a
ctiv
ity
Pass
ivit
y
Rel
axati
on
Ata
xia
Narc
osi
s
Pto
sis
Exop
hth
alm
os
es
Hyp
eract
ivit
y
Irri
tab
ilit
y
Ste
reoty
py
Tre
mors
Con
vu
lsio
n
Str
au
b t
ail
Basal - - - - -- - - - - - - - - - -
11.15
30 - - - - - - - - - + - - - - -
60 - - - - - - - - - + - - - - -
120 - - - - - - - - - + - -- - - -
180 - - - -- - - - - - - - -- -- - -
240 - - - - - - - - - - - - - --
24
h
- - - - - - - - - - - - - - -
48
h
- - - - - - - - - - - - - - -
20
Pharmacology Laboratory
SDM Centre for Research in Ayurveda and Allied sciences, Kuthpady, Udupi-
574118.
Pro forma for assessing Gross behaviour
Drug : M. Vita Capsule Date : 21/01/12
Group : 2000mg/kg Route: Oral
Animal: Rat-4(160g) Study: acute oral toxicity
Experiment conducted by: Head of the lab (Director):
Rat
No.4
Tim
e of
dru
g
ad
min
istr
ati
on
Tim
e i
nte
rval
(min
)
Exit
us
CNS Depression
ANS
CNS Stimulation
An
alg
esi
a
Oth
ers
Hyp
o a
ctiv
ity
Pass
ivit
y
Rel
axati
on
Ata
xia
Narc
osi
s
Pto
sis
Exop
hth
alm
os
es
Hyp
eract
ivit
y
Irri
tab
ilit
y
Ste
reoty
py
Tre
mors
Con
vu
lsio
n
Str
au
b t
ail
Basal - - - - -- - - - - - - - - - -
12.00
30 - - - - - - - - - - - - - - -
60 - - - - - - - - + + - - - - -
120 - - - - - - - - - + - -- - - -
180 - - - -- - - - - - - - -- -- - -
240 - - - - - - - - - - - - - --
24
h
- - - - - - - - - - - - - - -
48
h
- - - - - - - - - - - - - - -
21
Pharmacology Laboratory
SDM Centre for Research in Ayurveda and Allied sciences, Kuthpady, Udupi-
574118.
Pro forma for assessing Gross behaviour
Drug : M. Vita Capsule Date : 23/01/12
Group : 2000mg/kg Route: Oral
Animal: Rat-5(225g) Study: Acute oral toxicity
Experiment conducted by: Head of the lab (Director):
Rat
No5
Tim
e of
dru
g
ad
min
istr
ati
on
Tim
e i
nte
rval
(min
)
Exit
us
CNS Depression
ANS
CNS Stimulation
An
alg
esi
a
Oth
ers
Hyp
o a
ctiv
ity
Pass
ivit
y
Rel
axati
on
Ata
xia
Narc
osi
s
Pto
sis
Exop
hth
alm
os
es
Hyp
eract
ivit
y
Irri
tab
ilit
y
Ste
reoty
py
Tre
mors
Con
vu
lsio
n
Str
au
b t
ail
Basal - - - - -- - - - - - - - - - -
12.10
30 - - - - - - - - - + - - - - -
60 - - - - - - - - - + - - - - -
120 - - - - - - - - - - - -- - - -
180 - - - -- - - - - - - - -- -- - -
240 - - - - - - - - - - - - - --
24
h
- - - - - - - - - - - - - - -
48
h
- - - - - - - - - - - - - - -